Fintel reports that on March 14, 2025, Jefferies initiated coverage of Sana Biotechnology (NasdaqGS:SANA) with a Buy ...

Jefferies analyst Roger Song initiated coverage of Sana Biotechnology (SANA) with a Buy rating and $7 price target Sana is a clinical stage ...

We recently compiled a list of the Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In. In this article, we ...

In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other biotech stocks. No matter the market environment, you’ll always find ...

Pre-earnings options volume in Sana Biotechnology (SANA) is 2.0x normal with calls leading puts 150:1. Implied volatility suggests the market ...

Scilex (NASDAQ:SCLX – Get Free Report) and Sana Biotechnology (NASDAQ:SANA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two ...

Sana Biotechnology (NASDAQ:SANA – Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, March 6th. Analysts expect Sana Biotechnology to post earnings of ...

Sana Biotechnology SANA, a clinical-stage company, is expected to report its fourth-quarter results soon. The company leverages its proprietary hypoimmune technology to develop cell engineering ...

SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will ...

In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other companies Bezos is investing in. Since leaving his position as CEO of Amazon ...